share_log

綠葉製藥:自願性公告 - 廣譜新冠中和抗體BA-CovMab注射液在中國獲批進行臨床試驗

LUYE PHARMA: VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL FOR THE BROADLY NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 IN CHINA

Sep 12, 2022 07:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more